Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2007
10/18/2007WO2007116297A2 Use of aminapthone for the preparation of a medicament for treating arteriophaties
10/18/2007WO2007116287A1 Pharmaceutical composition that comprises an analgesic and vitamins
10/18/2007WO2007116243A2 Method for treating fibromyalgia and related conditions
10/18/2007WO2007116230A1 Azetidine derivatives as g-protein coupled receptor (gpr119 ) agonists
10/18/2007WO2007116229A1 Heterocyclic gpcr agonists
10/18/2007WO2007116228A1 Piperidine derivatives for treatment of alzheimer's disease
10/18/2007WO2007116149A1 Novel strontium salts of sulfonic acids, process for preparing them and the pharmaceutical compositions containing them
10/18/2007WO2007116138A1 Use of an anti-atherothrombotic compound for the production of medicaments for use in the treatment of vascular disorders
10/18/2007WO2007116136A1 Use of agomelatine for the production of medicaments for use in the treatment of generalized anxiety disorder
10/18/2007WO2007116135A1 Dimers of artemisinin derivatives, preparation thereof and therapeutic use thereof
10/18/2007WO2007116114A1 Use of delta opioid receptor agonists in the preparation of pharmaceutical compositions, pharmaceutical compositions that contain them and their applications in the treatment of tumours
10/18/2007WO2007116106A1 Novel compounds as antagonists of adenosine a1 receptors
10/18/2007WO2007116100A1 Condensed imidazole derivatives as aromatase inhibitors
10/18/2007WO2007116099A1 Imidazo compounds
10/18/2007WO2007116098A1 Spiro-imidazo compounds
10/18/2007WO2007116097A1 Condensed imidazole derivatives as aldosterone synthase inhibitors
10/18/2007WO2007116091A1 Novel nutraceutical compositions
10/18/2007WO2007116076A1 Mazindol combination in the treatment of attention deficit/hyperactivity
10/18/2007WO2007116074A1 Trimetazidine for use in the treatment of fibromyalgia syndrome and related conditions
10/18/2007WO2007116061A1 1-(2-aryl-2-oxoethyl)-3-phenyl-1, 4-diazaspiro [4.5]dec-3-en-2-one derivatives and their use as glycine transporter inhibitors
10/18/2007WO2007116052A1 Oral composition comprising dha and genistein for enhancing skin properties
10/18/2007WO2007116029A2 Combination comprising a) a pyrimidylaminobenzamide compound, and b) a thr315lle kinase inhibitor
10/18/2007WO2007116027A1 Oral composition comprising a polyunsaturated fatty acid and salicylic acid for obtaining an antiinflammatory effect in skin
10/18/2007WO2007116025A2 Use of c-src inhibitors in combination with a pyrimidylaminobenzamide compound for the treatment of leukemia
10/18/2007WO2007116015A1 Use of a lactose-derived c-glycoside compound as an agent for activating and regulating cutaneous immunity
10/18/2007WO2007116013A1 Use of a galactose-derived c-glycoside compound as an agent for activating and regulating cutaneous immunity
10/18/2007WO2007116012A1 Use of a d- and l-fucose-derived c-glycoside compound as an agent for activating and regulating cutaneous immunity
10/18/2007WO2007115999A1 2, 4-diaminopyrimidine derivatives and their use for the treatment of cancer
10/18/2007WO2007115997A2 Combination preparations from modafinil, ritalin and topiramat for use in cocaine dependency and/or for treating impulse control disorders
10/18/2007WO2007115990A1 Process for the preparation of pure irbesartan
10/18/2007WO2007115975A2 USE OF kappa OPIOID RECEPTOR ANTAGONIST-CONTAINING COMPOSITIONS FOR THE TREATMENT OF DISSOCIATIVE DISORDERS
10/18/2007WO2007115973A2 Food products for hypophosphoric normo-, hyper- and hypoproteic diets, and their use for nutrition of subjects in need of a low phosphorus level diet
10/18/2007WO2007115967A1 Crystalline isopropanol solvate of glucokinase activator
10/18/2007WO2007115966A1 Heterocyclic gaba alpha subtype selective receptor modulators
10/18/2007WO2007115947A1 Pyrrolo-quinoxalinone derivatives as antibacterials
10/18/2007WO2007115938A1 5-amido-2-carboxamide indoles
10/18/2007WO2007115935A1 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ACTIVE COMPOUNDS
10/18/2007WO2007115934A1 Oral composition with an antiageing effect on the skin
10/18/2007WO2007115933A1 Thiazolyldihydroindazoles
10/18/2007WO2007115932A1 Thiazolyl-dihydroquinazolines
10/18/2007WO2007115931A1 Thiazolyldihydrocyclopentapyrazoles for use as pi3-kinase inhibitors
10/18/2007WO2007115930A1 Thiazolyldihydroindazoles
10/18/2007WO2007115929A1 Thiazolyl-dihydroquinazolines
10/18/2007WO2007115822A1 Thienopyrimidines having mnkl /mnk2 inhibiting activity for pharmaceutical compositions
10/18/2007WO2007115821A2 Organic compounds
10/18/2007WO2007115820A1 Chromen-2-one derivatives
10/18/2007WO2007115808A1 Arginine prodrugs with high therapeutic activity
10/18/2007WO2007115798A1 Substituted phenylpiperidine derivatives as melanocortin-4 receptor modulators
10/18/2007WO2007115776A1 USE OF N- ( DIBENZ (b, f) OXEPIN-10-YLMETHYL ) N-METHYL-N- PROP- 2 -YNYLAMINE (OMIGAPIL) FOR THE PROPHYLAXIS AND / OR TREATMENT OF CONGENITAL MUSCULAR DYSTROPHY OR MYOPATHY RESULTING FROM COLLAGEN VI DEFICIENCY
10/18/2007WO2007115726A2 The homeobox transcription factor bsx and uses thereof for treating diseases, in particular obesity
10/18/2007WO2007115670A1 N-oxides of heterocyclic substituted bisarylureas for treating kinase-mediated diseases
10/18/2007WO2007115635A1 Biguanide-containing liposomes
10/18/2007WO2007115473A1 Pyrrole derivatives inhibitors, their curative uses
10/18/2007WO2007115430A1 Formulation of unsaturated salt of ampelopsin and its application
10/18/2007WO2007115414A1 Modified h2 relaxin for tumor suppression
10/18/2007WO2007115410A1 Compositions and methods for modulating gated ion channels
10/18/2007WO2007115409A1 Compositions and methods for modulating gated ion channels
10/18/2007WO2007115408A1 Compositions and methods for modulating gated ion channels
10/18/2007WO2007115403A1 Compositions and methods for modulating gated ion channels
10/18/2007WO2007115372A1 A method of modulating beta-amyloid peptide production
10/18/2007WO2007115364A1 Transcription factor modulator
10/18/2007WO2007100990A3 Octahydro-pyrrolo[3,4-b] pyrrole derivatives and their use as histamine-3 receptor ligands
10/18/2007WO2007100880A8 Cinnoline and quinazoline derivates as phosphodiesterase 10 inhibitors
10/18/2007WO2007100757A3 Transdermal therapeutic system comprising scopolamine
10/18/2007WO2007100561A3 Use of dha and ara in the preparation of a composition for preventing or treating obesity
10/18/2007WO2007098252A3 Methods and compositions for treating hyperalgesia
10/18/2007WO2007097470A3 Fused nitrogen- comprising heterocyclic compound
10/18/2007WO2007096740A3 Novel cephalosporins
10/18/2007WO2007095613A3 Use of benzo-heteroaryl sulfamide derivatives as neuroprotective agents
10/18/2007WO2007095608A3 Use of benzo-heteroaryl sulfamide derivatives for the treatment of disease modification of epileptogenesis
10/18/2007WO2007093425A3 Storage-stable oral dosage form of amoxicillin and clavulanic acid
10/18/2007WO2007092936A9 Method to treat gastric lesions
10/18/2007WO2007092721A3 Vitamin d analog: rak, methods and uses thereof
10/18/2007WO2007092720A3 Vitamin d analog: nel, methods and uses thereof
10/18/2007WO2007092574A3 Crystalline forms of ciclesonide
10/18/2007WO2007092531A3 Compounds and compositions as protein kinase inhibitors
10/18/2007WO2007087524A3 Treatment of acute respiratory distress syndrome
10/18/2007WO2007085420B1 Medicament comprising a hormone combination
10/18/2007WO2007084415A3 Compounds for the treatment of inflammatory disorders
10/18/2007WO2007077543A3 Sigma-2 receptor, method of screening of specific ligands and use of the same in diagnostic or therapeutic methods
10/18/2007WO2007077457A9 Treatment of equine laminitis with 5-ht1b/ 1d antagonists
10/18/2007WO2007076473A3 Substituted pyrimidinyloxy ureas useful as inhibitors of protein kinases
10/18/2007WO2007076228A8 2-(ih-thieno [3,2-c] pyrazol-3yl)-ih-indole derivatives and related compounds as tec kinase inhibitors for the treatment of inflammations and immunological disorders
10/18/2007WO2007075629A3 Phenoxypiperidines and analogs thereof useful as histamine h3 antagonists
10/18/2007WO2007071038A3 Compositions comprising one or more phytosterols and/or phytostanols, or derivatives thereof, and high hlb emulsifiers
10/18/2007WO2007067470A3 Benzimidazole non-aqueous compositions
10/18/2007WO2007065713B1 Use of 8-alpha-ergolines for the treatment of traumatic brain disorders
10/18/2007WO2007063509A3 Phosphocreatine complexes
10/18/2007WO2007059507A3 Compositions comprising lipoxygenase inhibitors and cyclodextrin
10/18/2007WO2007057849B1 2,3,4,5-tetrahydroxy-6-sulfooxyhexanoic acid and its metal salts for medical use
10/18/2007WO2007056023A3 Thiazole inhibitors targeting resistant kinase mutations
10/18/2007WO2007054257A3 Indene derivatives, their preparation and use as medicaments
10/18/2007WO2007052121A3 Multi-layered coating technology for taste masking
10/18/2007WO2007047692B1 Devices, systems and methods for improving memory and/or cognitive function through brain delivery of sirna
10/18/2007WO2007038620A3 Milnacipran for the long-term treatment of fibromyalgia syndrome
10/18/2007WO2007031933A3 Stable pharmaceutical composition comprising a pyrimidine-sulfamide
10/18/2007WO2007028117A3 P8 as a marker for heart failure
10/18/2007WO2007025069A3 Diazaspirodecane orexin receptor antagonists
10/18/2007WO2007022924B1 Pharmaceutical compositions with melting point depressant agents and method of making same
10/18/2007WO2007021694A3 Protein kinase modulation by hops and acacia products
1 ... 3538 3539 3540 3541 3542 3543 3544 3545 3546 3547 3548 3549 3550 3551 3552 3553 3554 3555 3556 3557 3558 ... 7860